TW366344B - Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives and pharmaceutical composition using the same - Google Patents

Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives and pharmaceutical composition using the same

Info

Publication number
TW366344B
TW366344B TW083108017A TW83108017A TW366344B TW 366344 B TW366344 B TW 366344B TW 083108017 A TW083108017 A TW 083108017A TW 83108017 A TW83108017 A TW 83108017A TW 366344 B TW366344 B TW 366344B
Authority
TW
Taiwan
Prior art keywords
group
alkoxy
mono
heteroaromatic ring
alkyl
Prior art date
Application number
TW083108017A
Other languages
English (en)
Inventor
Kiyofumi Ishikawa
Toshio Nagase
Toshiaki Mase
Takashi Hayama
Masaki Ihara
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/165,880 external-priority patent/US5389620A/en
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Application granted granted Critical
Publication of TW366344B publication Critical patent/TW366344B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
TW083108017A 1993-08-18 1994-08-31 Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives and pharmaceutical composition using the same TW366344B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP22510093 1993-08-18
JP28161393 1993-10-15
JP28567793 1993-10-21
US08/165,880 US5389620A (en) 1993-08-18 1993-12-14 Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives
JP8591494 1994-03-30

Publications (1)

Publication Number Publication Date
TW366344B true TW366344B (en) 1999-08-11

Family

ID=57941094

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083108017A TW366344B (en) 1993-08-18 1994-08-31 Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives and pharmaceutical composition using the same

Country Status (2)

Country Link
KR (1) KR100292735B1 (zh)
TW (1) TW366344B (zh)

Also Published As

Publication number Publication date
KR960703900A (ko) 1996-08-31
KR100292735B1 (ko) 2001-09-17

Similar Documents

Publication Publication Date Title
RS49921B (sr) Terapeutski biaril derivati
CA2169737A1 (en) Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives
DK584886A (da) Vanduoploeselige, mono- og disubstituerede derivater af rapamycin og farmaceutisk acceptable salte deraf
KR927003052A (ko) 2-아릴티아졸 유도체 및 그의 약제학적 조성물
HUP0402313A2 (hu) Szerotonin újrafelvételt gátló fenilpiperazin-származékok, az ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
NO20004624L (no) Benzensulfonamid-derivater og deres anvendelse som medikamenter
YU40799A (sh) Pirazinska jedinjenja
AU2001293233A1 (en) Aza heterocyclic derivatives and their therapeutic use
AU4929690A (en) Phenyl pyradazine-3(2H)one, thiadizin-2(3H)one, triazin-3(2H) one and oxadiazin-5(4H)one derivatives for the treatment of congestive heart failure
FI800047A (fi) Nya (piperidinylalkyl)kinazolinderivat
FI882081A0 (fi) 2-substituerade e-fusionerade (1,2,4) triazolo(1,5-c) pyrimidiner, farmaceutiska kompositioner och deras anvaendning.
WO2002026706A3 (en) 17-beta-hydroxysteroid dehydrogenase-ii inhibitors
AR068695A2 (es) Uso de un compuesto de tiazol que comprende un derivado de tiazol para la fabricacion de un medicamento para la prevencion y el tratamiento de en-fermedades causadas por la produccion anormal de citocinas y/o la acele-racion de la adhesion de neutrofilos y/o la produccion anormal de tnf- alfa
EA200000731A1 (ru) Альфа-аминоамидные производные, полезные в качестве анальгетических агентов
FI931763A0 (fi) 4,1-bensoxazepinderivat och deras anvaendning
HUP0203184A2 (hu) Izoxazolkarboxamid-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
YU46787B (sh) Derivati heteroaril 3-okso-propan-nitrila i postupak za njihovo dobijanje
IL136359A0 (en) Dihydrobenzofuran derivatives and pharmaceutical compositions containing the same
ATE247964T1 (de) Als inhibitoren der aicarftnützliche verbindungen
EP0183848A4 (en) POLYACAHETEROCYCLIC COMBINATING UNITS, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL COMPOSITION.
TW333532B (en) Benzopyrans
EP0324521A3 (en) Method of treating haematologic diseases and pharmaceutical compositions to be used therefor
HUP0105407A2 (hu) Triazolo[1,5-a]kinolinszármazékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek
AU643290B2 (en) Derivatives of 2-aminoalkyl-5-arylalkyl-1,3-dioxanes, their preparation and their therapeutic application
KR930006024A (ko) 이미다조 인돌리진 유도체 및 그의 제조방법

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees